Effectiveness of nonsteroidal mineralocorticoid receptor antagonists in patients with diabetic kidney disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness of nonsteroidal mineralocorticoid receptor antagonists in patients with diabetic kidney disease

Published:2022-04-20 Issue:3 Volume:135 Page:224-233
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Lerma Edgar¹^ORCID,White William B.²,Bakris George³

Affiliation:

1. Section of Nephrology, University of Illinois at Chicago/Advocate Christ Medical Center, Oak Lawn, IL, USA

2. Cardiology Center, University of Connecticut School of Medicine, Farmington, CT, USA

3. American Heart Association Comprehensive Hypertension Center, Department of Medicine, University of Chicago Medicine, Chicago, IL, USA

Funder

funding

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2022.2060598

Reference75 articles.

2. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

3. Randomised controlled trial of enalapril and blockers in non- diabetic chronic renal failure

4. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy

5. Effect of Calcium Channel or β-Blockade on the Progression of Diabetic Nephropathy in African Americans

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Uremic Toxins, Oxidative Stress, and Renal Fibrosis in Chronic Kidney Disease;Antioxidants;2024-06-03

2. Renal effects and safety between Asian and non‐Asian chronic kidney disease and type 2 diabetes treated with nonsteroidal mineralocorticoid antagonists;Journal of Diabetes;2024-05-16

3. Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions;Biomedicines;2024-05-15

4. Mineralocorticoid receptor antagonists and reno‐protection: What's the evidence & where do they fit? A guide for non‐specialists;Diabetes, Obesity and Metabolism;2024-05-07

5. Cardiorenal benefits of finerenone in different races and kidney function in patients with chronic kidney disease;Cardiorenal Medicine;2024-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3